Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Equity

v3.22.2
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Capital in Excess of Par
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020   39,759    
Beginning balance at Dec. 31, 2020 $ 711,002 $ 398 $ 3,222,959 $ (2,512,355)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (80,407)     (80,407)
Restricted stock units (in shares)   13    
Restricted stock units 2,609   2,609  
Warrant exercises (in shares)   6,385    
Warrant exercises 134,818 $ 64 134,754  
Ending balance (in shares) at Mar. 31, 2021   46,157    
Ending balance at Mar. 31, 2021 768,022 $ 462 3,360,322 (2,592,762)
Beginning balance (in shares) at Dec. 31, 2020   39,759    
Beginning balance at Dec. 31, 2020 711,002 $ 398 3,222,959 (2,512,355)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (92,102)      
Ending balance (in shares) at Jun. 30, 2021   46,289    
Ending balance at Jun. 30, 2021 757,288 $ 463 3,361,282 (2,604,457)
Beginning balance (in shares) at Mar. 31, 2021   46,157    
Beginning balance at Mar. 31, 2021 768,022 $ 462 3,360,322 (2,592,762)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (11,695)     (11,695)
Restricted stock units (in shares)   132    
Restricted stock units 961 $ 1 960  
Ending balance (in shares) at Jun. 30, 2021   46,289    
Ending balance at Jun. 30, 2021 757,288 $ 463 3,361,282 (2,604,457)
Beginning balance (in shares) at Dec. 31, 2021   61,371    
Beginning balance at Dec. 31, 2021 1,865,768 $ 614 4,012,358 (2,147,204)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) 39,737     39,737
Restricted stock units (in shares)   6    
Restricted stock units 2,790   2,790  
Common stock issued for Primexx Acquisition (in shares)   117    
Common stock issued for Primexx Acquisition 6,295 $ 1 6,294  
Ending balance (in shares) at Mar. 31, 2022   61,494    
Ending balance at Mar. 31, 2022 1,914,590 $ 615 4,021,442 (2,107,467)
Beginning balance (in shares) at Dec. 31, 2021   61,371    
Beginning balance at Dec. 31, 2021 1,865,768 $ 614 4,012,358 (2,147,204)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) 387,746      
Ending balance (in shares) at Jun. 30, 2022   61,716    
Ending balance at Jun. 30, 2022 2,259,337 $ 617 4,018,178 (1,759,458)
Beginning balance (in shares) at Mar. 31, 2022   61,494    
Beginning balance at Mar. 31, 2022 1,914,590 $ 615 4,021,442 (2,107,467)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) 348,009     348,009
Restricted stock units (in shares)   244    
Restricted stock units (1,899) $ 2 (1,901)  
Common stock issued for Primexx Acquisition (in shares)   (22)    
Common stock issued for Primexx Acquisition (1,363)   (1,363)  
Ending balance (in shares) at Jun. 30, 2022   61,716    
Ending balance at Jun. 30, 2022 $ 2,259,337 $ 617 $ 4,018,178 $ (1,759,458)